Global Diagnostic Radiopharmaceuticals & Contrast Media Market-Market Dynamics
The growth of the market during the forecast period is expected to be sluggish, as a number of factors such as declining prices of radiopharmaceuticals and contrast media and limitations imposed by health insurance companies are restraining the growth of the market. The factors such as shorter half-life of radiopharmaceuticals, stringent regulatory guidelines, and competition from conventional diagnostic procedures are hindering the growth of this market. However, the market is expected to recover during the forecast period, influenced by factors such as the increasing incidence of diseases that require radiopharmaceuticals and contrast media such as cardiac and digestive tract ailments.
The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. There are many technical innovations in the market that are expected to contribute to the growth of the market during the forecast period. There has been an increase in the volume of the procedures that are being carried out; the CT market by itself is growing at 5-6% annually. The sales of MR contrast media and ultrasound contrast media have increased in the last few years.
The diagnostics segment of radiopharmaceuticals holds the largest share as radioisotopes are widely used in SPECT and PET. The cardiology segment has the largest application of SPECT and PET in oncology.
Major Companies in the Sector Include:
This Report Offers:
Market definition along with identification of key drivers and restraints for the market.
Market analysis with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
220.127.116.11 Advances in Technology such as Radio Tracers
18.104.22.168 New Application of Existing Techniques
22.214.171.124 Increasing Incidence of Cancers and Cardiac Diseases
5.3.2 Market Restraints
126.96.36.199 High costs of the techniques- Not Easily Affordable
188.8.131.52 Limited Health Insurance Coverage
184.108.40.206 Short Half-life of Radiopharmaceuticals
220.127.116.11 Strict Regulatory Policies
18.104.22.168 Lack of Reimbursement
22.214.171.124 Substitution of Products Is High Because of High Competition
5.4 Market Segmentation
5.4.1 Contrast Media
126.96.36.199 By Procedure
188.8.131.52.1 X-ray/Computed Tomography (CT)
184.108.40.206.1.1 Iodinated Contrast Media
220.127.116.11.1.2 Barium-Based Contrast Media
18.104.22.168.2 Magnetic Resonance Imaging (MRI)
22.214.171.124.2.1 Gadolinium-Based Contrast Media
126.96.36.199.3.1 Micro-Bubble Contrast Media
188.8.131.52 SPECT Radiopharmaceuticals
184.108.40.206 PET Radiopharmaceuticals
5.4.3 By Geography
220.127.116.11 North America
18.104.22.168.5 Spain & Portugal
22.214.171.124.4 Australia & New Zealand
126.96.36.199.5 South Korea
188.8.131.52 Middle East & Africa
184.108.40.206.5 South Africa
220.127.116.11 Latin America
6. Industry Analysis
6.1 Key Trends and Developments
6.2 Porterâ€™s Five Forces
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Consumers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitute Products and Services
6.2.5 Competitive Rivalry within the Industry
7. Competitive Landscape
7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships
7.3 New Product Launches
7.4 Recommendations to New Market Players
8. Company Profiles
8.1 Bayer Healthcare
8.2 GE Healthcare
8.3 Guerbet Group
8.4 Bracco Imaging SpA
8.5 Mallinckrodt PLC
8.6 Lantheus Medical Imaging
8.7 AMAG Pharmaceuticals, Inc.
8.9 CMC Contrast AB
8.10 Daiichi Sankyo Co., Ltd.
8.11 Nordion, Inc.
8.12 Agfa Healthcare
9. Analyst Outlook for Investment Opportunities
10. Future Outlook of the Market